Cleared Traditional

Lianfa Safety Lancet (Five Models: NPA, PA, PA2, TPA, and APA) (K222376) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K222376 · Shandong Lianfa Medical Plastic Products Co. , Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
59d
Days
Class 2
Risk

K222376 is an FDA 510(k) clearance for the Lianfa Safety Lancet (Five Models: NPA, PA, PA2, TPA, and APA). Classified as Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature (product code FMK), Class II - Special Controls.

Submitted by Shandong Lianfa Medical Plastic Products Co. , Ltd. (Jinan, CN). The FDA issued a Cleared decision on October 3, 2022 after a review of 59 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4850 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Shandong Lianfa Medical Plastic Products Co. , Ltd. devices

Submission Details

510(k) Number K222376 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 05, 2022
Decision Date October 03, 2022
Days to Decision 59 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 115d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMK Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4850
Definition A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Non-reusable Base (including An Integral Sharps Injury Prevention Feature) That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes. The Integral Sharps Injury Prevention Feature Allows The Device To Be Used Once And Then Renders It Inoperable And Incapable Of Further Use.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Manton Business and Technology Services
Charles Shen

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FMK Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature

All 63
Devices cleared under the same product code (FMK) and FDA review panel - the closest regulatory comparables to K222376.
Unistik® Pro
K222303 · Owen Mumford, Ltd. · Oct 2022
SafetiCET Safety Lancet
K221783 · Nsp Tech Pte, Ltd. · Oct 2022
Disposable Safety Lancets
K221778 · Suzhou Kyuan Medical Apparatus Co., Ltd. · Oct 2022
Safety Lancet
K222090 · Ningbo Medsun Medical Co., Ltd. · Sep 2022
SurgiLance® Safety Lancet
K222224 · Medipurpose Pte. , Ltd. · Sep 2022
Lancet
K221839 · Hebei Xinle Sci&Tech Co., Ltd. · Sep 2022